The brief repeatable battery of neuropsychological tests for multiple sclerosis: a preliminary serial study

Abstract

The Brief Repeatable Battery of Neuropsychological Tests (BRB-N) for MS consisting of the selective reminding, 10136 spatial recall, symbol digit modalities, paced auditory serial addition (PASAT) and word list generation tests is a sensitive measure of early cognitive impairment in MS patients. We administered it to 19 chronic stable MS patients every 60 days for 120 days to examine variability. The mean coefficient of variation for the tests ranged from 18% to 22%. A significant practice effect was seen in the PASAT results (P<0.05) using the Wilcoxon signed rank test These results suggest that cognitive fluctuations analogous to motor fluctuations may occur in MS patients and that the BRB-N may be useful in clinical trials of agents expected to alter cognitive function in MS patients if test-retest variability and practice effects are taken into account Further study is warranted.

Keywords

psychological testing cognitive impairment clinical trials

Get full access to this article

View all access options for this article.

References

1 Franklin GM , Nelson LM , Filley CJ , Heaton RK . (1989) Cognitive loss in multiple sclerosis, case reports and review of the literature. Arch Neurol 46: 162–167.

2 Mclntosh-Michaelis SA et al. (1991) The prevalence of cognitive impairment in a community sample of multiple sclerosis. Br J Clin Psychol 30: 333–348.

3 Peyser JM , Poser CM . (1986) Neuropsychological correlates of multiple sclerosis. In: Filskov SB , Boll TJ (eds) Handbook of Clinical Psychology Wiley & Sons: New York, 385–397.

4 Rao SM et al. (1991) Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns and prediction. Neurology 41: 685–691.

5 Buschke H , Fuld PA . Evaluating storage, retention and retrieval in disordered memory and learning. Neurology 24: 1019–1025.

6 Rao SM et al. (1991) dysfunction in multiple sclerosis. II. Impact on employment and social functioning. Neurology 41: 692–696.

7 Peyser JM , Rao GJ , LaRocca NG , Kaplan E . (1990) Guidelines for neuropsychological research in multiple sclerosis. Arch Neurol 47: 685–691.

8 Poser CM et al. (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13: 227–231.

9 Bever CT et al. (1994) The efficacy and toxicity of oral 3, 4 diaminopyridine in multiple sclerosis patients (Abstract 970S). Neurology 44: (suppl 2): A374.

10.

10 Bever CT et al. (1990) Preliminary trial of 3, 4-diamino-pyridine in patients with multiple sclerosis. Ann Neurol 27: 421–427.

11.

11 Kurtzke JF . (1983) Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology 33: 1444–1452.

12.

12 Hauser SL et al. (1983) Intensive immunosuppression in progressive multiple sclerosis: A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange and ACTH. N Engl J Med 308: 173–180.

13.

13 Rao SM , Cognitive Function Study Group, NMSS . (1990) A Manual for the Brief Repeatable Battery of Neuropsychology Tests in Multiple Sclerosis National Multiple Sclerosis Society: New York.

14.

14 Smith A . (1982) The Symbol Digits Modalities Test Manual, revised Western Psychological Services: Los Angeles.

15.

15 Gronwall DMA . (1977) Paced auditory serial addition task: A measure of recovery from concussion. Perceptual Motor Skills 44: 367–373.

16.

16 Anastasia A . (1968) Psychological Testing Macmillan: Toronto.

17.

17 Kerlinger FN . (1973) Foundations of Behavioral Research Holt, Rinehart, and Winston: New York.

18.

18 Lezak M . (1982) Neuropsychological Assessment Oxford University Press: New York.

19.

19 Dyche DM , Johnson DA . (1991) Development and evaluation of CHI PASAT, an attention test for children. II. Test-retrest reliability and practice effect for normal sample. Perceptual Motor Skills 72: 563–572.

20.

20 Stuss DT , Stethem LL , Poirer CA . (1987) Comparison of 3 tests of attention and rapid information processing across 6 age groups. Clin Neuropsych 1: 139–152.